Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer

The original version of this article unfortunately contained a mistake. The co-authors’ names were incorrect.

Saved in:
Bibliographic Details
Published in:Cancer chemotherapy and pharmacology 2018-09, Vol.82 (3), p.419-419
Main Authors: Patnaik, Amita, Gordon, Michael, Tsai, Frank, Papadopoulos, Kyriakos P., Rasco, Drew, Beeram, Muralidhar, Fu, Siqing, Janku, Filip, Hynes, Scott M., Gundala, Sushma R., Willard, Melinda D., Zhang, Wei, Lin, Aimee Bence, Hong, David
Format: Article
Language:English
Subjects:
Bispecific antibodies
Cancer
Cancer Research
Correction
Epidermal growth factor receptors
Medicine
Medicine & Public Health
Metastases
Oncology
Pharmacology/Toxicology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The original version of this article unfortunately contained a mistake. The co-authors’ names were incorrect.
ISSN:0344-5704
1432-0843
DOI:10.1007/s00280-018-3641-5